Sunday, Sep 21st

Last update02:57:29 PM GMT






You are here: News BioMedTech

Kymab wins patent battle with Regeneron

Christian-GroendahlCambridge UK antibody technology pioneer Kymab has won an important European patent battle against Regeneron.

Hauser and Horizon back Axol with near £1m new cash

Dr Hermann Hauser, Silicon Valley Hall of Fame luminary and co-founder & partner at Amadeus Capital PartnersCambridge UK stem cell technology startup Axol Bioscience has secured £800,000 in new equity funding – bringing on board an elite team of heavy-hitters in the life-science investment world.

Thumbs up for European drug rehab study

Jerry-WalkerIntelligent Fingerprinting – the company behind a revolutionary non-invasive and real-time drug screening technique that analyses the sweat in a fingerprint – has been offered a substantial grant from the EUREKA Eurostars Programme that will allow its technology to be adapted and trialled in an Anglo-Finnish opioid drug rehabilitation study.

Cambridge duo lead biopharma revolution

Frank-Craig-sphereNeighbouring businesses Sphere Fluidics and Cambridge Consultants have joined forces to promote analysis technology that they believe will revolutionise biopharma.

UK-US alliance plots new breast cancer diagnostic

Julie Barnes, Abcodia's CEOCambridge UK medical technology trailblazer Abcodia is working with OncoCyte Corporation in California to develop a new test for early detection of breast cancer.

Sphere Medical lights fuse to commercial lift off

Professor Jean-Louis Vincent, a world authority on intensive care medicines,  joins Sphere Medical boardSphere Medical is set for commercial lift off with its new blood gas analyser, Proxima 3.

New nicotine inhaler wins key approval

Consort Medical’s chief executive Jonathan GlennCambridge UK medical technology company Consort Medical has completed production facilities to make a new nicotine inhaler for British American Tobacco.

Future patients will be the ‘Wired Well’

Simon Karger, head of surgical and interventional products at Cambridge ConsultantsAdvanced technology based on neurostimulation devices such as chip implants will wire future patients for recovery against a range of conditions from migraine to Parkinson’s disease – even obesity – Cambridge UK MedTech experts are predicting.

Cambridge Cognition charges towards profitability

Cambridge Cognition CEO Nick Kerton Medical technology business Cambridge Cognition is cutting a swathe through legacy losses and charging towards profitability in 2015, CEO Nick Kerton has assured shareholders.

All change at Abcam as Milner quits CEO role

Jonathan Milner steps aside as CEO of AbcamJonathan Milner, who built Abcam from zero in 1998 to global life science hero in 2014, has stepped aside as CEO and handed the reins to chief marketing officer Alan Hirzel, who only joined the board in January.

Amgen’s Cambridge boost for future life science leaders

George-FreemanAmgen and the University of Cambridge have joined forces to stage a venture designed to develop future life science leaders. The symposium is being held  in Cambridge today and tomorrow.

Innova Biosciences strikes gold dust

Babraham-Research-CampusInnova Biosciences, a specialist provider of bioconjugation products and services, has commercially launched InnovaGOLD  – a new range of ultra-high quality gold nanoparticles.

Ranier load sharing aid secures key approval

Ranier-Anatom CInternational medical markets would appear to be beckoning for a fresh innovation from Cambridge-based hothouse Ranier Technology. The company has been granted a CE mark for its new fusion cage, Anatom-C, which is made from a unique polymeric material and provides critical support for people with spinal problems.

Chris Ullman takes CEO role at Isogenica

Chris-UllmanIsogenica has appointed Dr Chris Ullman as CEO with effect from September 29 following the decision by Dr Kevin Matthews to join a publicly listed polymer technology company.

Pfizer buys into Cambridge life science innovation

Roger-PedersenStem cell technology pioneer, DefiniGEN Ltd has joined the Pfizer-inspired European Bank for induced pluripotent stem cells (EBiSC) consortium.

Cambridge entrepreneur steers global medtech innovator

Catherine-Beech 2014Cambridge UK life science entrepreneur Dr Catherine Beech is spearheading a truly international startup initially targeting eye disease but with applications in cancer and other disease areas.

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  9 
  •  10 
  •  Next 
  •  End 
  • »

Page 1 of 63